藥明生物(02269.HK):未核實清單有別於實體名單 對公司業務並無影響
美國商務部的工業與安全局(BIS)將33家中國企業列入「未核實清單」(UVL),當中包括藥明生物(02269.HK)旗下附屬公司。藥明生物發表聲明,指UVL不是更為人熟知的美國「實體名單」或「黑名單」,認為主因是美國政府機構無法對產品進行最終用途驗證,美國供應商因此無法出口相關設備。
公司一直在進口生物反應器的某些硬件控制器和某些中空纖維過濾器,這些控制器受美國出口管制,但在過去十年中已獲得美國商務部的批准,強調公司遵守所有美國出口管制法規,不會將這些物品再出口或轉售給任何其他實體,美國商務部有一個例行程序來驗證這些在現場的正確使用,由於疫情大流行,該過程在過去兩年中尚未完成,對公司業務或對全球合作夥伴的持續服務沒有影響。
藥明補充,由於上海和無錫的設施建設後不需要此類設備,因此對集團進口影響非常小。此次事件對公司業務沒有造成影響,公司還正在採取臨時措施,在檢查前將這些子公司從名單中刪除。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.